Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
RecruitingNCT07570212Phase: NAStarted 2025-12-22
Summary
This clinical trial aims to evaluate whether individualized targeted repetitive transcranial magnetic stimulation (rTMS) can improve motor and non-motor symptoms in patients with parkinsonian disorder
Eligibility
Sex
ALL
Min Age
30 Years
Max Age
80 Years
Locations
Peking University First HospitalBeijing, Beijing Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07570212